Development of a high-throughput screening paradigm for the discovery of small-molecule modulators of adenylyl cyclase: identification of an adenylyl cyclase 2 inhibitor.
about
A gain-of-function mutation in adenylate cyclase 3 protects mice from diet-induced obesityThe role of adenylyl cyclase isoform 6 in β-adrenoceptor signalling in murine airways.Cyclic Adenosine 3',5'-Monophosphate Elevation and Biological Signaling through a Secretin Family Gs-Coupled G Protein-Coupled Receptor Are Restricted to a Single Adenylate Cyclase Isoform.Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties.Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase.β2-adrenergic receptor control of endosomal PTH receptor signaling via Gβγ.Adenylate cyclase-centred microdomains.Selectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms.Design and Synthesis of Fluorescent Acyclic Nucleoside Phosphonates as Potent Inhibitors of Bacterial Adenylate Cyclases.Bisamidate Prodrugs of 2-Substituted 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis.International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.Systems Biomedicine of Rabies Delineates the Affected Signaling Pathways.Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia.Synthesis of α-branched acyclic nucleoside phosphonates as potential inhibitors of bacterial adenylate cyclases.Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets.Dop1 enhances conspecific olfactory attraction by inhibiting miR-9a maturation in locusts.
P2860
Q27335317-4F6CB386-579C-413B-A85A-CF496D1CDF3EQ34795724-53A5D7E9-0945-41CC-B0AB-884687A489B6Q35600378-6E3718F3-7982-4B9F-9F57-4CC3930D103DQ36287047-FEDD6E32-A9DA-48BD-BA22-15B54E06143AQ37270490-A754EA78-D391-4C10-8325-5E885C585C30Q37660917-B2ECCB39-11FA-4F6C-A049-9607D72274AAQ38237737-705AC381-3D00-42A0-B93B-FFC660830D08Q38336214-F5F1A582-3ECE-40BB-B5E0-BDF17F33B3E8Q38806723-9FA01A80-1D67-4C23-A230-752A3AEDC6F0Q38857408-819DEC19-83B6-4AB5-9D18-A007EC09B89FQ39158851-81D45DF0-AD63-46DE-BBC8-F1E52D46BD75Q39166204-3A760117-D1B2-4385-837B-434BA53F1A55Q39809596-51F45DCF-ED34-4FE5-8AB8-D608E4C073D3Q46242316-0B71C492-791E-4F1B-9F84-78886D2CCBF7Q50865512-B63590F3-3C1D-47F4-B3C9-B2CC87F51CBCQ52879829-E4B12EFE-9DD2-4BAC-9801-756847ADE9B7
P2860
Development of a high-throughput screening paradigm for the discovery of small-molecule modulators of adenylyl cyclase: identification of an adenylyl cyclase 2 inhibitor.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Development of a high-throughp ...... adenylyl cyclase 2 inhibitor.
@ast
Development of a high-throughp ...... adenylyl cyclase 2 inhibitor.
@en
Development of a high-throughp ...... adenylyl cyclase 2 inhibitor.
@nl
type
label
Development of a high-throughp ...... adenylyl cyclase 2 inhibitor.
@ast
Development of a high-throughp ...... adenylyl cyclase 2 inhibitor.
@en
Development of a high-throughp ...... adenylyl cyclase 2 inhibitor.
@nl
prefLabel
Development of a high-throughp ...... adenylyl cyclase 2 inhibitor.
@ast
Development of a high-throughp ...... adenylyl cyclase 2 inhibitor.
@en
Development of a high-throughp ...... adenylyl cyclase 2 inhibitor.
@nl
P2093
P2860
P356
P1476
Development of a high-throughp ...... adenylyl cyclase 2 inhibitor.
@en
P2093
Amy S Bogard
Cameron S Brand
Carmen W Dessauer
Evan P S Pratt
Gregory H Hockerman
Jason M Conley
Ruqiang Xu
Val J Watts
P2860
P304
P356
10.1124/JPET.113.207449
P407
P577
2013-09-05T00:00:00Z